John Flanagan

John Flanagan, Ph.D.

Professor of Cell Biology (HMS)

John Flanagan, Ph.D., did his undergraduate training at the University of Oxford in biochemistry and his graduate training at the University of Cambridge, UK in molecular biology. His postdoctoral training was at Harvard Medical School in the Genetics department, focused on cell-cell signaling, after which he joined the Department of Cell Biology as a faculty member.

The Flanagan lab studies how cell-cell signaling molecules set up spatial pattern, particularly in the development and regeneration of connections in the nervous system.

Harvard Medical School

Dept. of Cell Biology, LHRRB 601B

240 Longwood Avenue

Boston, MA 02115

Lab Phone: 617-432-4096

Similarities and differences in the way transmembrane-type ligands interact with the Elk subclass of Eph receptors.
Authors: Authors: Brambilla R, Brückner K, Orioli D, Bergemann AD, Flanagan JG, Klein R.
Mol Cell Neurosci
View full abstract on Pubmed
Scanning laser tomography in benign intracranial hypertension.
Authors: Authors: Hudson C, Shah S, Flanagan JG, Brahma A, Ansons A.
Lancet
View full abstract on Pubmed
The Waterloo Vision and Mobility Study: postural control strategies in subjects with ARM.
Authors: Authors: Elliott DB, Patla AE, Flanagan JG, Spaulding S, Rietdyk S, Strong G, Brown S.
Ophthalmic Physiol Opt
View full abstract on Pubmed
ELF-2, a new member of the Eph ligand family, is segmentally expressed in mouse embryos in the region of the hindbrain and newly forming somites.
Authors: Authors: Bergemann AD, Cheng HJ, Brambilla R, Klein R, Flanagan JG.
Mol Cell Biol
View full abstract on Pubmed
Indirect fundus biomicroscopy.
Authors: Authors: Flanagan JG, Prokopich CL.
Ophthalmic Physiol Opt
View full abstract on Pubmed
Complementary gradients in expression and binding of ELF-1 and Mek4 in development of the topographic retinotectal projection map.
Authors: Authors: Cheng HJ, Nakamoto M, Bergemann AD, Flanagan JG.
Cell
View full abstract on Pubmed
Membrane-bound LERK2 ligand can signal through three different Eph-related receptor tyrosine kinases.
Authors: Authors: Brambilla R, Schnapp A, Casagranda F, Labrador JP, Bergemann AD, Flanagan JG, Pasquale EB, Klein R.
EMBO J
View full abstract on Pubmed
Interactions between the Flk-1 receptor, vascular endothelial growth factor, and cell surface proteoglycan identified with a soluble receptor reagent.
Authors: Authors: Chiang MK, Flanagan JG.
Growth Factors
View full abstract on Pubmed
Waterloo Vision and Mobility Study: gait adaptations to altered surfaces in individuals with age-related maculopathy.
Authors: Authors: Spaulding SJ, Patla AE, Elliott DB, Flanagan J, Rietdyk S, Brown S.
Optom Vis Sci
View full abstract on Pubmed
Identification and cloning of ELF-1, a developmentally expressed ligand for the Mek4 and Sek receptor tyrosine kinases.
Authors: Authors: Cheng HJ, Flanagan JG.
Cell
View full abstract on Pubmed